DJIA 17,098.45 18.88 0.11%
NASDAQ 4,580.27 0.00 0.00%
S&P 500 2,003.37 6.63 0.33%
market minute promo

6.22 0.06 (0.97%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ARIA $6.22 0.97%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.16
Previous Close $6.16
Daily Range $6.16 - $6.36
52-Week Range $2.15 - $23.00
Market Cap $1.2B
P/E Ratio -4.71
Dividend (Yield) $0.00 (0.0%)
Volume 3,560,396
Average Daily Volume 8,043,662
Current FY EPS -$1.17

Sector

Healthcare

Industry

Drugs

Ariad Pharmaceuticals, Inc. (ARIA) Description

The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules. Website: http://www.ariad.com/

News & Commentary

Ariad Stock's Biggest Risk Is Its Only Hope

f Ariad continued to see high rates of Iclusig-induced serious adverse events and/or deaths amongst cancer patients in its new trials, the stock could be in serious trouble.

Why Ariad Pharmaceuticals (ARIA) Stock Is Up Today

GNC, Southern Copper And Others Insiders Have Been Buying

Biotechs With Insider Buying

5 Stocks Insiders Love Right Now

InsiderInsights.com Daily Round Up: 8/19/14

ARIAD Falls on Wider-than-Expected Loss, Revenues Miss - Analyst Blog

Ariad Pharmaceuticals' (ARIA) CEO Harvey Berger on Q2 2014 Results - Earnings Call Transcript

Why Ariad Pharmaceuticals (ARIA) Stock Is Down Today

Sector Update: Health Care

Sector Update: Health Care Shares Lower Pre-Market

See More ARIA News...

ARIA's Top Competitors

ARIA $6.22 (0.97%)
Current stock: ARIA
AMGN $139.38 (0.50%)
Current stock: AMGN
GILD $107.56 (0.05%)
Current stock: GILD
BIIB $343.04 (0.53%)
Current stock: BIIB